Outlook Therapeutics

$Outlook Therapeutics(OTLK)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001178913-26-000311  Act: 34  Size: 12 KB 网页链接

$Outlook Therapeutics(OTLK)$ DEF 14A Other definitive proxy statements Accession Number: 0001140361-26-002406  Act: 34  Size: 6 MB 网页链接

$Outlook Therapeutics(OTLK)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001140361-26-002407  Act: 34  Size: 3 MB 网页链接

$Outlook Therapeutics(OTLK)$ ARS Annual Report to Security Holders Accession Number: 0001140361-26-002408  Act: 34  Size: 1 MB 网页链接

$Outlook Therapeutics(OTLK)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-26-000066  Act: 34  Size: 221 KB 网页链接

$Outlook Therapeutics(OTLK)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001104659-25-123264  Act: 34  Size: 9 MB 网页链接

$Outlook Therapeutics(OTLK)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-25-122786  Act: 34  Size: 274 KB 网页链接

$Outlook Therapeutics(OTLK)$ 8-K Current report, item 8.01 Accession Number: 0001104659-25-111316  Act: 34  Size: 187 KB 网页链接

$Outlook Therapeutics(OTLK)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-25-105633  Act: 34  Size: 205 KB 网页链接

$Outlook Therapeutics(OTLK)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000902664-25-004475  Act: 34  Size: 13 KB 网页链接

$Outlook Therapeutics(OTLK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001649989-25-000010  Size: 8 KB 网页链接

$Outlook Therapeutics(OTLK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001649989-25-000009  Size: 8 KB 网页链接

$Outlook Therapeutics(OTLK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001649989-25-000008  Size: 8 KB 网页链接

$Outlook Therapeutics(OTLK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001649989-25-000007  Size: 5 KB 网页链接

$Outlook Therapeutics(OTLK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001649989-25-000005  Size: 8 KB 网页链接

$Outlook Therapeutics(OTLK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001649989-25-000006  Size: 8 KB 网页链接

$Outlook Therapeutics(OTLK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001649989-25-000004  Size: 5 KB 网页链接

$Outlook Therapeutics(OTLK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001649989-25-000003  Size: 8 KB 网页链接

$Outlook Therapeutics(OTLK)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-25-094558  Act: 34  Size: 233 KB 网页链接

$Outlook Therapeutics(OTLK)$ 8-K Current report, item 5.02 Accession Number: 0001104659-25-087886  Act: 34  Size: 189 KB 网页链接